antonello santini
antonello santini
Affiliazione sconosciuta
Email verificata su
Citata da
Citata da
Metal-based nanoparticles as antimicrobial agents: an overview
E Sánchez-López, D Gomes, G Esteruelas, L Bonilla, AL Lopez-Machado, ...
Nanomaterials 10 (2), 292, 2020
Polymeric nanoparticles: production, characterization, toxicology and ecotoxicology
A Zielińska, F Carreiró, AM Oliveira, A Neves, B Pires, DN Venkatesh, ...
Molecules 25 (16), 3731, 2020
The therapeutic potential of apigenin
B Salehi, A Venditti, M Sharifi-Rad, D Kręgiel, J Sharifi-Rad, A Durazzo, ...
International journal of molecular sciences 20 (6), 1305, 2019
Polyphenols: A concise overview on the chemistry, occurrence, and human health
A Durazzo, M Lucarini, EB Souto, C Cicala, E Caiazzo, AA Izzo, ...
Phytotherapy Research 33 (9), 2221-2243, 2019
Antidiabetic potential of medicinal plants and their active components
B Salehi, A Ata, N V. Anil Kumar, F Sharopov, K Ramírez-Alarcón, ...
Biomolecules 9 (10), 551, 2019
Milk thistle (Silybum marianum): A concise overview on its chemistry, pharmacological, and nutraceutical uses in liver diseases
L Abenavoli, AA Izzo, N Milić, C Cicala, A Santini, R Capasso
Phytotherapy research 32 (11), 2202-2213, 2018
Nutraceuticals: Opening the debate for a regulatory framework
A Santini, SM Cammarata, G Capone, A Ianaro, GC Tenore, L Pani, ...
British journal of clinical pharmacology 84 (4), 659-672, 2018
Nutraceuticals: A paradigm of proactive medicine
A Santini, GC Tenore, E Novellino
European Journal of Pharmaceutical Sciences 96, 53-61, 2017
Tramadol hydrochloride: pharmacokinetics, pharmacodynamics, adverse side effects, co-administration of drugs and new drug delivery systems
M Vazzana, T Andreani, J Fangueiro, C Faggio, C Silva, A Santini, ...
Biomedicine & Pharmacotherapy 70, 234-238, 2015
From pharmaceuticals to nutraceuticals: Bridging disease prevention and management
P Daliu, A Santini, E Novellino
Expert Review of Clinical Pharmacology 12 (1), 1-7, 2019
Advantages of hyaluronic acid and its combination with other bioactive ingredients in cosmeceuticals
AM Juncan, DG Moisă, A Santini, C Morgovan, LL Rus, AL Vonica-Țincu, ...
Molecules 26 (15), 4429, 2021
Metabolic engineering of a reduced-genome strain of Escherichia coli for L-threonine production
JH Lee, BH Sung, MS Kim, FR Blattner, BH Yoon, JH Kim, SC Kim
Microbial Cell Factories 8, 1-12, 2009
Nutraceuticals-shedding light on the grey area between pharmaceuticals and food
A Santini, E Novellino
Expert Review of Clinical Pharmacology 11 (6), 545-547, 2018
Sugar-lowering drugs for type 2 diabetes mellitus and metabolic syndrome—Review of classical and new compounds: Part-I
R Vieira, SB Souto, E Sánchez-López, A López Machado, P Severino, ...
Pharmaceuticals 12 (4), 152, 2019
Nanoparticle delivery systems in the treatment of diabetes complications
EB Souto, SB Souto, JR Campos, P Severino, TN Pashirova, ...
Molecules 24 (23), 4209, 2019
Chemical and Nutritional Characterization of Seed Oil from Cucurbita maxima L. (var. Berrettina) Pumpkin
D Montesano, F Blasi, MS Simonetti, A Santini, L Cossignani
Foods 7 (3), 30, 2018
Nanotoxicology and nanosafety: Safety-by-design and testing at a glance
A Zielińska, B Costa, MV Ferreira, D Miguéis, JMS Louros, A Durazzo, ...
International Journal of Environmental Research and Public Health 17 (13), 4657, 2020
A decade of nutraceutical patents: where are we now in 2018?
P Daliu, A Santini, E Novellino
Expert opinion on therapeutic patents 28 (12), 875-882, 2018
Abelmoschus esculentus (L.): Bioactive Components’ Beneficial Properties—Focused on Antidiabetic Role—For Sustainable Health Applications
A Durazzo, M Lucarini, E Novellino, EB Souto, P Daliu, A Santini
Molecules 24 (1), 38, 2018
Preferred conformation of the terminally blocked (Aib)10 homo‐oligopeptide: A long, regular 310‐helix
C Toniolo, M Crisma, GM Bonora, E Benedetti, B Dl Blasio, V Pavone, ...
Biopolymers: Original Research on Biomolecules 31 (1), 129-138, 1991
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20